is trametinib a new standard for low-grade serous ovarian cancer?
Published 1 year ago • 347 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
55:39
latest updates in low grade serous ovarian cancer treatment and research
-
0:24
what’s the latest in low-grade serous ovarian cancer?
-
1:01:03
what’s the latest in low-grade serous ovarian cancer?
-
1:59
trametinib: new treatment for recurrent lgsoc
-
53:51
ask the experts: towards new therapies for low grade serous ovarian cancer
-
1:50
david gershenson, md, elaborates on the role of mek inhibitor trametinib in lgsc
-
6:40
dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade...
-
1:38
low grade ovarian cancer – clinical and molecular aspects
-
31:45
treatment of low grade serous ovarian cancer: one size doesn't fit all
-
5:53
current treatment standards for primary ovarian cancer
-
1:01:31
research update in rarer ovarian cancers
-
50:04
ovarian cancer update - parvin f. peddi, md | ucla health
-
24:51
unraveling ovarian cancer: new treatment of rare sub-types
-
29:05
current treatment standards for primary ovarian cancer
-
30:05
updates on rare ovarian cancers (2022)
-
26:25
rare ovarian cancers: advances & updates
-
34:16
basics of hereditary ovarian cancer diagnosis and treatment